Clinical trial
Combination Chemotherapy in Treating Women With Breast Cancer
NCT00003679 · Scottish Cancer Therapy Network, Other · Unknown status
Key facts
| NCT number | NCT00003679 |
|---|---|
| Title | Combination Chemotherapy in Treating Women With Breast Cancer |
| Official title | A Randomised Comparative Trial of Adriamycin + Taxotere vs. Adriamycin + Cyclophosphamide as Primary Medical Therapy for Patients With Potentially Operable Breast Cancer Greater Than or Equal to 3 cm Diameter, Locally Advanced, or Inflammatory Disease |
| Lead sponsor | Scottish Cancer Therapy Network, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | cyclophosphamide, docetaxel, doxorubicin hydrochloride, tamoxifen citrate, conventional surgery, radiation therapy |
| Enrollment | 350 |
| Start date | Nov 1, 1998 |
| First posted | Dec 5, 2003 |
| Last update posted | Nov 6, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: